Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00438139
Other study ID # NIDA-CPU-0011-1
Secondary ID
Status Terminated
Phase Phase 1
First received February 20, 2007
Last updated January 13, 2017
Start date March 2007
Est. completion date March 2007

Study information

Verified date February 2007
Source National Institute on Drug Abuse (NIDA)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determine if there are potential significant interactions before conducting outpatient studies.


Recruitment information / eligibility

Status Terminated
Enrollment 6
Est. completion date March 2007
Est. primary completion date March 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Must be between the ages of 18 to 45 years of age

- Must be in good general health

- Must meet DSM-IV criteria for marijuana dependence and are non- treatment seekers at the time of study

- Must be able to provide written informed consent

- Must be able to provide 1 marijuana positive urine specimen (> 50 ng/mL) within the 28-day screening period

- If female and of child bearing potential, must agree to use birth control.

Exclusion

Criteria:

- Please contact site for more information.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dronabinol


Locations

Country Name City State
United States Uniformed Services University of Health Science Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiovascular responses
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00875836 - Buspirone Treatment for Marijuana Dependence Phase 4
Completed NCT00893269 - The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep Phase 1
Completed NCT00490269 - Ph1 Marinol Interaction Study - Part 2 - 1 Phase 1
Completed NCT02579421 - Hormones and Reduction in Co-users of Marijuana and Nicotine N/A
Terminated NCT01598896 - Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia Phase 2/Phase 3
Completed NCT00373295 - Effect of Baclofen on Marijuana Withdrawal and Relapse Phase 2
Active, not recruiting NCT01827332 - Effect of Oxytocin on Craving and Therapy Response N/A
Completed NCT01335789 - Effect of Oxytocin on Stress in Marijuana Users N/A
Completed NCT02955329 - Vaping THC From Electronic Cigarettes Phase 3
Completed NCT02439814 - Pregnenolone and Marijuana Dependence Phase 2
Completed NCT01039415 - Attempts to Stop/Reduce Marijuana Among Dependent Users N/A
Completed NCT01347762 - Nabilone for Cannabis Dependence: A Pilot Study Phase 2/Phase 3
Completed NCT00270803 - The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of Marijuana N/A
Completed NCT01020019 - Combined Pharmacotherapy for Cannabis Dependency Phase 2/Phase 3
Completed NCT02030665 - Marijuana Treatment Project 4 N/A
Completed NCT00107588 - Marijuana Treatment Project - 3 N/A
Completed NCT02011516 - Baclofen Effects on Marijuana Dependence Phase 2
Recruiting NCT00598052 - Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy N/A
Completed NCT00350649 - Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management Phase 2
Completed NCT00374127 - Comparison Between Marijuana Smoked in Cigarette Paper Versus Cigar Paper Phase 2